Title | Type | SJR | H index | Total Docs. (2009) | Total Docs. (3years) | Total Refs. (2009) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2009) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Advanced Drug Delivery Reviews | journal | 4.230 Q1 | 366 | 139 | 364 | 15218 | 4422 | 315 | 12.18 | 109.48 | |
2 | Nature Reviews Drug Discovery | journal | 6.955 Q1 | 391 | 196 | 485 | 7293 | 6011 | 387 | 11.47 | 37.21 | |
3 | Trends in Pharmacological Sciences | journal | 5.016 Q1 | 244 | 81 | 283 | 5573 | 2791 | 267 | 9.25 | 68.80 | |
4 | Reviews of Physiology Biochemistry and Pharmacology | journal | 3.408 Q1 | 70 | 0 | 20 | 0 | 144 | 20 | 8.92 | 0.00 | |
5 | Natural Product Reports | journal | 2.925 Q1 | 211 | 77 | 186 | 11182 | 1455 | 181 | 7.70 | 145.22 | |
6 | Nano Today | journal | 4.977 Q1 | 175 | 48 | 88 | 3092 | 614 | 53 | 7.50 | 64.42 | |
7 | Current Opinion in Pharmacology | journal | 3.520 Q1 | 148 | 116 | 305 | 6206 | 2210 | 274 | 7.09 | 53.50 | |
8 | Neuropsychopharmacology | journal | 3.590 Q1 | 249 | 255 | 835 | 16245 | 5588 | 800 | 6.85 | 63.71 | |
9 | Cellular and Molecular Life Sciences | journal | 3.995 Q1 | 261 | 299 | 843 | 28820 | 5655 | 839 | 6.45 | 96.39 | |
10 | Neurotherapeutics | journal | 2.326 Q1 | 136 | 75 | 198 | 6608 | 1175 | 183 | 6.28 | 88.11 | |
11 | Journal of Controlled Release | journal | 2.922 Q1 | 313 | 284 | 898 | 10523 | 5898 | 869 | 6.24 | 37.05 | |
12 | Drug Discovery Today | journal | 1.979 Q1 | 215 | 154 | 459 | 8116 | 2858 | 433 | 6.23 | 52.70 | |
13 | Nanotoxicology | journal | 1.478 Q1 | 107 | 34 | 51 | 1379 | 290 | 50 | 5.69 | 40.56 | |
14 | Journal of Nanobiotechnology | journal | 1.490 Q1 | 109 | 10 | 39 | 361 | 177 | 37 | 5.44 | 36.10 | |
15 | Clinical Pharmacokinetics | journal | 1.494 Q1 | 184 | 60 | 212 | 4237 | 1153 | 202 | 5.36 | 70.62 | |
16 | Particle and Fibre Toxicology | journal | 2.160 Q1 | 119 | 31 | 49 | 1670 | 331 | 46 | 5.18 | 53.87 | |
17 | Current Opinion in Drug Discovery and Development | journal | 1.722 Q1 | 85 | 73 | 215 | 5063 | 1028 | 197 | 5.07 | 69.36 | |
18 | Toxicological Sciences | journal | 2.018 Q1 | 207 | 331 | 910 | 16093 | 4910 | 862 | 4.97 | 48.62 | |
19 | Journal of Molecular Medicine | journal | 2.375 Q1 | 157 | 129 | 396 | 5819 | 1940 | 376 | 4.95 | 45.11 | |
20 | Pharmacogenomics Journal | journal | 1.676 Q1 | 95 | 44 | 146 | 1939 | 760 | 145 | 4.92 | 44.07 | |
21 | Expert Opinion on Investigational Drugs | journal | 1.251 Q1 | 117 | 165 | 481 | 12080 | 1956 | 449 | 4.54 | 73.21 | |
22 | Apoptosis : an international journal on programmed cell death | journal | 1.825 Q1 | 128 | 129 | 506 | 9689 | 2186 | 502 | 4.48 | 75.11 | |
23 | Critical Reviews in Toxicology | journal | 2.075 Q1 | 129 | 38 | 105 | 5576 | 694 | 99 | 4.47 | 146.74 | |
24 | Current Drug Metabolism | journal | 1.223 Q1 | 122 | 90 | 255 | 12668 | 1277 | 245 | 4.44 | 140.76 | |
25 | Journal of Antimicrobial Chemotherapy | journal | 1.902 Q1 | 221 | 583 | 1558 | 13684 | 6869 | 1238 | 4.29 | 23.47 | |
26 | BioDrugs | journal | 1.124 Q1 | 79 | 35 | 126 | 2782 | 442 | 117 | 4.24 | 79.49 | |
27 | Psychopharmacology | journal | 2.178 Q1 | 214 | 389 | 1063 | 23283 | 4796 | 1025 | 4.23 | 59.85 | |
28 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 1.728 Q1 | 99 | 25 | 69 | 3489 | 351 | 64 | 4.20 | 139.56 | |
29 | Antiviral Research | journal | 1.277 Q1 | 151 | 132 | 369 | 6144 | 1570 | 367 | 4.14 | 46.55 | |
30 | Handbook of Experimental Pharmacology | journal | 1.728 Q1 | 110 | 155 | 390 | 19347 | 1316 | 371 | 4.11 | 124.82 | |
31 | Neuropharmacology | journal | 1.807 Q1 | 191 | 250 | 800 | 15008 | 3134 | 797 | 4.08 | 60.03 | |
32 | Antiviral Therapy | journal | 1.619 Q1 | 93 | 134 | 418 | 4995 | 1651 | 411 | 4.07 | 37.28 | |
33 | International Journal of Neuropsychopharmacology | journal | 1.897 Q1 | 125 | 136 | 294 | 6496 | 1149 | 263 | 4.07 | 47.76 | |
34 | Drug and Alcohol Dependence | journal | 2.025 Q1 | 187 | 263 | 725 | 12249 | 3017 | 700 | 3.98 | 46.57 | |
35 | Expert Review of Vaccines | journal | 1.278 Q1 | 105 | 156 | 310 | 11295 | 1142 | 276 | 3.97 | 72.40 | |
36 | Current Pharmaceutical Biotechnology | journal | 1.249 Q1 | 97 | 85 | 170 | 5699 | 606 | 150 | 3.88 | 67.05 | |
37 | Drug Safety | journal | 1.384 Q1 | 140 | 99 | 305 | 5046 | 1257 | 257 | 3.88 | 50.97 | |
38 | Ecotoxicology | journal | 1.380 Q1 | 107 | 133 | 212 | 5298 | 717 | 211 | 3.86 | 39.83 | |
39 | Expert Opinion on Therapeutic Targets | journal | 1.469 Q1 | 106 | 116 | 345 | 11796 | 1225 | 321 | 3.82 | 101.69 | |
40 | European Journal of Pharmaceutics and Biopharmaceutics | journal | 1.533 Q1 | 185 | 195 | 650 | 8882 | 2538 | 645 | 3.76 | 45.55 | |
41 | Mutagenesis | journal | 1.169 Q1 | 102 | 62 | 173 | 2947 | 693 | 167 | 3.74 | 47.53 | |
42 | Current Opinion in Molecular Therapeutics | journal | 1.249 Q1 | 67 | 77 | 212 | 5421 | 730 | 194 | 3.72 | 70.40 | |
43 | Environmental Pollution | journal | 2.002 Q1 | 301 | 440 | 1429 | 19704 | 5855 | 1410 | 3.71 | 44.78 | |
44 | Current Opinion in Investigational Drugs | journal | 1.276 Q1 | 83 | 136 | 371 | 9871 | 1308 | 339 | 3.66 | 72.58 | |
45 | Toxicology Letters | journal | 1.090 Q1 | 163 | 295 | 628 | 11836 | 2385 | 607 | 3.64 | 40.12 | |
46 | Journal of Computer-Aided Molecular Design | journal | 1.085 Q1 | 119 | 78 | 195 | 3338 | 715 | 188 | 3.63 | 42.79 | |
47 | Expert Opinion on Biological Therapy | journal | 1.137 Q1 | 102 | 141 | 454 | 11591 | 1569 | 448 | 3.57 | 82.21 | |
48 | Expert Opinion on Drug Metabolism and Toxicology | journal | 0.951 Q2 | 100 | 125 | 259 | 11138 | 976 | 253 | 3.57 | 89.10 | |
49 | European Neuropsychopharmacology | journal | 1.309 Q1 | 130 | 110 | 313 | 5066 | 1113 | 306 | 3.53 | 46.05 | |
50 | International Journal of Pharmaceutics | journal | 1.399 Q1 | 258 | 525 | 1714 | 17057 | 6428 | 1700 | 3.53 | 32.49 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®